Genomics market size to increase by USD 18,244.34 million: Analysis of major players as well as the key contributor region - Technavio
North America will account for 37% of the global genomics market's growth
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- North America will account for 37% of the market's growth during the forecast period. The increase in research funding and the growing developments in precision medicine and personalized therapies are driving the growth of the regional market. The Genomics Market by Solution, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 10.53% and register an incremental growth of USD 18,244.34 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF Sample Report.
Company profiles
The genomics market report includes information on the key products and recent developments of leading vendors, including:
Abcam plc: The company offers genomics such as multi-omic cytometry single-cell immune profiling solutions.
Agilent Technologies Inc: The company offers genomics such as NGS workflow for translational research.
Becton Dickinson and Co: The company offers genomics such as BD Rhapsody single cell analysis system.
BGI Genomics Co. Ltd: The company offers genomics such as DNA sequencing and RNA sequencing.
Bio Rad Laboratories Inc: The company offers genomics such as CFX opus real-time PCR system.
Danaher Corp.
Eppendorf SE
F. Hoffmann La Roche Ltd.
Hamilton Bonaduz AG
Illumina Inc.
Myriad Genetics Inc.
New England Biolabs Inc.
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc.
Promega Corp.
To gain access to more vendor profiles available with Technavio, buy the report!
Market dynamics
The market is driven by factors such as rising investments in genomics research and development, reduction in the cost of genetic sequencing, and increasing demand for creating and upgrading genome databases. However, the varying regulations in genomics research and testing are hindering market growth.
Competitive analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample
Market segmentation
By solution, the market is segmented into products and services. The products segment accounted for the largest share of the market.
By geography, the market is segmented into North America, Europe, Asia, and the Rest of World. North America held the largest share of the market.
Related Reports:
Chromatography Market by Technology, End-user, and Geography - Forecast and Analysis 2023-2027: The chromatography market is estimated to grow at a CAGR of 6.82% between 2022 and 2027. The size of the market is forecast to increase by USD 3,785.83 million. The Increasing demand for ion exchange membranes for chromatography in R&D is notably driving the market growth, although factors such as product limitations the market growth.
Forensic Technologies Market by Technique, Application, and Geography - Forecast and Analysis 2023-2027: The forensic technologies market is estimated to grow at a CAGR of 11.89% between 2022 and 2027. The size of the market is forecast to increase by USD 6,583.87 million. The increasing crime rate demanding better investigation methods is notably driving the market growth, although factors such as lack of technical know-how or technical professionals may impede the market growth.
What are the key data covered in this genomics market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the genomics market between 2023 and 2027
Precise estimation of the size of the genomics market and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the genomics market across North America, Europe, Asia, and the Rest of World
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of genomics market vendors
Genomics Market Scope
Report Coverage
Details
Page number
163
Base year
2022
Historic period
2017-2021
Forecast period
2023-2027
Growth momentum & CAGR
Accelerate at a CAGR of 10.53%
Market growth 2023-2027
USD 18244.34 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
9.93
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 37%
Key countries
US, France, Germany, UK, and China
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and Perkin Elmer Inc
Market dynamics
Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Browse for Technavio "Health Care" Research Reports
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Solution
Exhibit 06: Executive Summary ? Chart on Market Segmentation by Application
Exhibit 07: Executive Summary ? Chart on Incremental Growth
Exhibit 08: Executive Summary ? Data Table on Incremental Growth
Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global genomics market 2017 - 2021
Exhibit 18: Historic Market Size ? Data Table on Global genomics market 2017 - 2021 ($ million)
Exhibit 158: Pacific Biosciences of California Inc. - Overview
Exhibit 159: Pacific Biosciences of California Inc. - Product / Service
Exhibit 160: Pacific Biosciences of California Inc. - Key offerings
12.16 QIAGEN NV
Exhibit 161: QIAGEN NV - Overview
Exhibit 162: QIAGEN NV - Product / Service
Exhibit 163: QIAGEN NV - Key news
Exhibit 164: QIAGEN NV - Key offerings
12.17 Standard BioTools Inc.
Exhibit 165: Standard BioTools Inc. - Overview
Exhibit 166: Standard BioTools Inc. - Product / Service
Exhibit 167: Standard BioTools Inc. - Key news
Exhibit 168: Standard BioTools Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...